Skip to main content
. 2022 Jan 5;11(1):77. doi: 10.3390/biology11010077

Table 1.

Comparison of the main clinical features characterizing ALS2 gene mutation-related diseases, i.e., IAHSP, JPLS, and JALS.

IAHSP JPLS JALS
Inheritance Autosomal recessive Autosomal recessive Autosomal recessive
Age of onset 1–3 years old 1–3 years old 4–8 years old
Life expectancy Adulthood Adulthood 7 months to 17 years old
Genetic causes ALS2 mutation ALS2 mutation ALS2 mutation
(Other forms are caused by SETX, FUS, UBQLN2, SPG11, SIGMAR1)
Neuron alterations Degeneration of both upper and lower motor neurons Progressive degeneration, upper motor neurons Degeneration of both upper and lower motor neurons
Symptoms Lower limb weakness and spasticity progressing towards quadriplegia, wheelchair dependence by the age of 10, followed by tetraparesis, feeding dependence on gastrostomy Lower limb weakness and spasticity, wheelchair dependence by adolescence, motor speech impairment, saccadic eye movements Lower limb weakness and spasticity, face muscle spasticity, bladder dysfunction, dysarthria, sensory disturbances, and sometimes mental retardation and sclerosis